Drug
KPS-0373
KPS-0373 is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
3
60%
Ph phase_3
2
40%
Phase Distribution
0
Early Stage
3
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
2(40.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(4)
Detailed Status
Completed4
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 23 (60.0%)
Phase 32 (40.0%)
Trials by Status
completed480%
recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
recruitingphase_3
Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration
NCT07040137
completedphase_3
An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT02889302
completedphase_2
A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT01384435
completedphase_2
A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT01004016
completedphase_2
Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT00863538
Clinical Trials (5)
Showing 5 of 5 trials
NCT07040137Phase 3
Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration
NCT02889302Phase 3
An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT01384435Phase 2
A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT01004016Phase 2
A Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
NCT00863538Phase 2
Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5